- Home
- LEG vs COLL Comparison
LEG vs COLL Comparison
Compare LEG & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEG | COLL |
|---|---|---|
| Founded | 1883 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LEG | COLL |
|---|---|---|
| Price | $11.86 | $45.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $10.50 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.8M | 289.3K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | 1.28 |
| Revenue | ★ $5,203,900,000.00 | $631,449,000.00 |
| Revenue This Year | N/A | $26.20 |
| Revenue Next Year | $4.41 | $3.54 |
| P/E Ratio | ★ $7.89 | $35.16 |
| Revenue Growth | ★ 1.37 | N/A |
| 52 Week Low | $6.48 | $23.23 |
| 52 Week High | $13.00 | $50.79 |
Technical Indicators
Market Signals| Indicator | LEG | COLL |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 44.45 |
| Support Level | $11.61 | $44.59 |
| Resistance Level | $12.33 | $46.66 |
| Average True Range (ATR) | 0.52 | 1.41 |
| MACD | -0.09 | -0.13 |
| Stochastic Oscillator | 41.92 | 23.12 |
Price Performance
Historical ComparisonAbout LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.